(Total Views: 503)
Posted On: 03/28/2022 11:21:04 AM
Post# of 6857
Here is a little something that could help new lookers. A little old but i'm sure its still in effect.
Owings Mills, Maryland —August 8, 2011– Univec, Inc. (UNVC) a specialty pharmaceutical
company, announces it has been issued a FDA labeler code. This is the prefix for each National
Drug Code (NDC) on products that is manufactured and distributed by Univec for the company’s
Specialty Pharmaceuticals. The National Drug Code is a unique identifier assigned by the FDA to
identify the manufacturer of a prescription drug product intended for human use. The NDC
number is also used in the electronic claim processing for payment by third party entities and eprescribing for physicians.
David L. Dalton, President and CEO of Univec stated. “ We are delighted to make progress
in our new business model. The National Drug Codes are very important not only from the
standpoint of the FDA, but it also allows payment from Medicare, Medicaid, Insurance
companies and other third party payment systems. This is another milestone reached in
placement of a solid foundation to build and grow the company. We thank our associates,
shareholders and investors for the support and confidence they have shown the company. ”
About Univec
Univec, Inc. A minority business enterprise (MBE) is a Specialty Pharmaceutical Company that
manufactures and distributes high cost Specialty Pharmaceuticals. Specialty Pharmaceuticals are high cost
products that are not usually dispensed in retail pharmacies but require special handling and a complex
pharmaceutical regime. The company is focused on diseases such as Sickle Cell Anemia, Cancer,
HIV/Aids, Hepatitis C., Multiple Sclerosis, Hemophilia and Drug addiction.
PPSI (PHYSICIAN AND PHARMACEUTICAL SERVICES, INC.) a subsidiary of Univec
promotes and pays for pharmaceutical products though its network of pharmacies. PPSI
eliminates the need for the pharmaceutical companies to distribute actual drug samples to
physicians reducing potential liability for the physician while maintaining clinical oversight and
drug interaction checks for the patient. The company through it’s “StarterScript” allows in lieu of
a physician sample, a voucher or a co-payment card to be provide to the patient for a trial supply
of medication redeemed in any of the nearly 55,000 retail pharmacies utilizing the PPSI real-time
processing system
Owings Mills, Maryland —August 8, 2011– Univec, Inc. (UNVC) a specialty pharmaceutical
company, announces it has been issued a FDA labeler code. This is the prefix for each National
Drug Code (NDC) on products that is manufactured and distributed by Univec for the company’s
Specialty Pharmaceuticals. The National Drug Code is a unique identifier assigned by the FDA to
identify the manufacturer of a prescription drug product intended for human use. The NDC
number is also used in the electronic claim processing for payment by third party entities and eprescribing for physicians.
David L. Dalton, President and CEO of Univec stated. “ We are delighted to make progress
in our new business model. The National Drug Codes are very important not only from the
standpoint of the FDA, but it also allows payment from Medicare, Medicaid, Insurance
companies and other third party payment systems. This is another milestone reached in
placement of a solid foundation to build and grow the company. We thank our associates,
shareholders and investors for the support and confidence they have shown the company. ”
About Univec
Univec, Inc. A minority business enterprise (MBE) is a Specialty Pharmaceutical Company that
manufactures and distributes high cost Specialty Pharmaceuticals. Specialty Pharmaceuticals are high cost
products that are not usually dispensed in retail pharmacies but require special handling and a complex
pharmaceutical regime. The company is focused on diseases such as Sickle Cell Anemia, Cancer,
HIV/Aids, Hepatitis C., Multiple Sclerosis, Hemophilia and Drug addiction.
PPSI (PHYSICIAN AND PHARMACEUTICAL SERVICES, INC.) a subsidiary of Univec
promotes and pays for pharmaceutical products though its network of pharmacies. PPSI
eliminates the need for the pharmaceutical companies to distribute actual drug samples to
physicians reducing potential liability for the physician while maintaining clinical oversight and
drug interaction checks for the patient. The company through it’s “StarterScript” allows in lieu of
a physician sample, a voucher or a co-payment card to be provide to the patient for a trial supply
of medication redeemed in any of the nearly 55,000 retail pharmacies utilizing the PPSI real-time
processing system
(5)
(0)Scroll down for more posts ▼
